Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)
Argentina · Delayed Price · Currency is ARS 1,555.00
-30.00 (-1.89%)
Sep 3, 2026, 4:32 PM BRT
BCBA:RICH Ratios and Metrics
Market cap in millions ARS. Fiscal year is January - December.
Millions ARS. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 125,972 | 159,484 | 144,949 | 56,405 | 31,412 | 17,927 | |
Market Cap Growth | 39.29% | 10.03% | 156.98% | 79.56% | 75.22% | 92.21% |
Enterprise Value | 366,771 | 370,409 | 272,829 | 98,345 | 44,967 | 27,171 |
Last Close Price | 1560.00 | 1934.82 | 1725.06 | 671.29 | 373.84 | 211.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.66 | 51.65 | 4.62 | - | 61.72 | 15.56 |
PS Ratio | 1.10 | 1.26 | 1.20 | 0.66 | 0.55 | 0.55 |
PB Ratio | 1.06 | 1.71 | 1.69 | 1.13 | 0.99 | 1.71 |
P/TBV Ratio | 1.14 | 1.87 | 1.84 | 1.35 | 1.12 | 1.94 |
P/FCF Ratio | 17.40 | - | 122.72 | - | - | - |
P/OCF Ratio | 11.87 | 85.46 | 19.60 | - | - | 2.47 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.22 | 2.92 | 2.26 | 1.16 | 0.78 | 0.84 |
EV/EBITDA Ratio | 19.39 | 11.23 | 9.26 | 5.92 | 3.90 | 5.26 |
EV/EBIT Ratio | 20.62 | 12.39 | 13.71 | 8.52 | 4.87 | 6.05 |
EV/FCF Ratio | 50.65 | - | 230.98 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 2.05 | 2.65 | 2.20 | 4.10 | 2.10 | 2.14 |
Debt / EBITDA Ratio | 12.83 | 7.26 | 6.41 | 12.34 | 5.80 | 4.33 |
Debt / FCF Ratio | 33.63 | - | 159.94 | - | - | - |
Net Debt / Equity Ratio | 2.01 | 2.48 | 2.05 | 4.07 | 1.85 | 0.80 |
Net Debt / EBITDA Ratio | 13.11 | 7.00 | 5.97 | 12.23 | 5.11 | 1.63 |
Net Debt / FCF Ratio | 33.09 | -6.43 | 148.84 | -8.12 | -1.72 | -2.76 |
Asset Turnover | 0.30 | 0.33 | 0.36 | 0.37 | 0.65 | 1.03 |
Inventory Turnover | 1.08 | 1.29 | 1.62 | 1.59 | 2.57 | 4.61 |
Quick Ratio | 0.50 | 0.65 | 0.74 | 0.40 | 0.92 | 1.20 |
Current Ratio | 0.92 | 1.01 | 1.21 | 0.87 | 1.55 | 1.66 |
Return on Equity (ROE) | 13.21% | 2.39% | 46.08% | -58.17% | 2.35% | 14.95% |
Return on Assets (ROA) | 2.90% | 4.90% | 3.66% | 3.11% | 6.53% | 8.91% |
Return on Invested Capital (ROIC) | 3.53% | 2.70% | 6.44% | 6.71% | 3.36% | 14.72% |
Return on Capital Employed (ROCE) | 5.30% | 10.00% | 7.40% | 4.50% | 9.40% | 14.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.93% | 1.94% | 21.64% | -41.89% | 1.62% | 6.43% |
FCF Yield | 5.75% | -22.52% | 0.81% | -44.36% | -108.79% | -16.98% |
Dividend Yield | 2.11% | - | 1.56% | - | - | - |
Payout Ratio | - | 85.20% | - | - | 311.30% | 11.72% |
Buyback Yield / Dilution | 0.01% | 0.00% | -0.00% | 0.04% | -0.06% | 0.00% |
Total Shareholder Return | 2.12% | 0.00% | 1.56% | 0.04% | -0.06% | 0.00% |